Pearl River Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,067
Closed -$355K 228
2024
Q2
$355K Buy
8,067
+1,317
+20% +$57.9K 0.06% 333
2024
Q1
$339K Buy
6,750
+2,458
+57% +$123K 0.05% 370
2023
Q4
$259K Buy
+4,292
New +$259K 0.04% 423